Cargando…
Correction: Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
Autores principales: | Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445425/ https://www.ncbi.nlm.nih.gov/pubmed/34529648 http://dx.doi.org/10.1371/journal.pmed.1003785 |
Ejemplares similares
-
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
por: Basu, Sanjay, et al.
Publicado: (2017) -
Black-White Cardiovascular Disease Disparities After Target-Based
Versus Personalized Benefit–Based Lipid and Blood Pressure
Treatment
por: Basu, Sanjay, et al.
Publicado: (2017) -
Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
por: Basu, Sanjay, et al.
Publicado: (2018) -
Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD
por: Wu, Yaqian, et al.
Publicado: (2022) -
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial
por: Ghazi, Lama, et al.
Publicado: (2023)